Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Y Jay

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Pediatric Cardiology|September 25, 2013
Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failureAura A Sanchez Mejia, Kathleen E Simpson, Charles F Hildebolt, et al.
The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology|September 16, 2004
Function follows form: cardiac conduction system defects in Nkx2-5 mutationPatrick Y Jay, Brett S Harris, Antje Buerger, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Tiered Sympathetic Control of Cardiac Function Revealed by Viral Tracing and Single Cell Transcriptome ProfilingSachin Sharma, Russell Littman, John Tompkins, et al.
Nature|April 2, 2015
The maternal-age-associated risk of congenital heart disease is modifiableClaire E Schulkey, Suk D Regmi, Rachel A Magnan, et al.
Journal of the American College of Cardiology|August 6, 2025
Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With CardiomyopathyKarola S Jering, Marianna Fontana, Hicham Skali, et al.
Nature Medicine|August 6, 2025
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trialKarola S Jering, Marianna Fontana, Olivier Lairez, et al.
Elife|May 10, 2023
Tiered sympathetic control of cardiac function revealed by viral tracing and single cell transcriptome profilingSachin Sharma, Russell Littman, John D Tompkins, et al.
Circulation|March 10, 2010
Heterogeneity of genetic modifiers ensures normal cardiac developmentJulia B Winston, Jonathan M Erlich, Courtney A Green, et al.
European Journal of Heart Failure|June 26, 2026
Consistent Efficacy of Vutrisiran Across Sexes in Transthyretin Cardiac Amyloidosis: Evidence from the HELIOS-B TrialJosephine Mansell, Xiaowen Wang, Karola S Jering, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Pediatric Cardiology|September 25, 2013
Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failureAura A Sanchez Mejia, Kathleen E Simpson, Charles F Hildebolt, et al.
The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology|September 16, 2004
Function follows form: cardiac conduction system defects in Nkx2-5 mutationPatrick Y Jay, Brett S Harris, Antje Buerger, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Tiered Sympathetic Control of Cardiac Function Revealed by Viral Tracing and Single Cell Transcriptome ProfilingSachin Sharma, Russell Littman, John Tompkins, et al.
Nature|April 2, 2015
The maternal-age-associated risk of congenital heart disease is modifiableClaire E Schulkey, Suk D Regmi, Rachel A Magnan, et al.
Journal of the American College of Cardiology|August 6, 2025
Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With CardiomyopathyKarola S Jering, Marianna Fontana, Hicham Skali, et al.
Nature Medicine|August 6, 2025
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trialKarola S Jering, Marianna Fontana, Olivier Lairez, et al.
Elife|May 10, 2023
Tiered sympathetic control of cardiac function revealed by viral tracing and single cell transcriptome profilingSachin Sharma, Russell Littman, John D Tompkins, et al.
Circulation|March 10, 2010
Heterogeneity of genetic modifiers ensures normal cardiac developmentJulia B Winston, Jonathan M Erlich, Courtney A Green, et al.
European Journal of Heart Failure|June 26, 2026
Consistent Efficacy of Vutrisiran Across Sexes in Transthyretin Cardiac Amyloidosis: Evidence from the HELIOS-B TrialJosephine Mansell, Xiaowen Wang, Karola S Jering, et al.
Pageof 7